Mahesh Krishnan - Apr 1, 2023 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC. (KDNY)

Role
Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Stock symbol
KDNY
Transactions as of
Apr 1, 2023
Transactions value $
-$21,261
Form type
4
Date filed
4/4/2023, 09:14 PM
Previous filing
Apr 5, 2022
Next filing
Aug 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KDNY Common Stock Options Exercise +2.2K 2.2K Apr 1, 2023 Direct F1
transaction KDNY Common Stock Sale -$21.3K -924 -42.02% $23.01 1.28K Apr 4, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Restricted Stock Units Options Exercise $0 -2.2K -33.32% $0.00 4.4K Apr 1, 2023 Common Stock 2.2K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated February 10, 2023.
F3 Each RSU represents a contingent right to receive one share of Issuer's common stock.
F4 The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on April 1, 2023, until fully vested subject to the Reporting Person's provision of service to the Issuer on each vesting date.